Denudatin B exhibits significant anti-inflammatory and immunomodulatory activities, making it a compound of interest in the development of therapeutics for autoimmune and chronic inflammatory diseases. It has been studied for its ability to inhibit the production of pro-inflammatory cytokines such as TNF-α and IL-6, suggesting potential application in conditions like rheumatoid arthritis and inflammatory bowel disease. Additionally, Denudatin B shows antiproliferative effects against certain cancer cell lines, indicating possible use in oncology research, particularly in targeting tumor growth and metastasis. Its natural origin and bioactivity also support its role as a lead compound in drug discovery for designing novel anti-cancer and anti-inflammatory agents.